Latest News and Press Releases

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The...

New York, USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sarcopenia Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight  The sarcopenia market...

PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...

PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...

BURLINGTON, Ontario, April 07, 2020 (GLOBE NEWSWIRE) -- While people are stockpiling common immune-strengthening supplements like vitamins C, D and zinc, one group of overlooked nutrients that are...

BURLINGTON, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- As we shed more clothes during the summer, one of the body’s most valuable assets is exposed: muscle tone. Those who have more of it not only...

BURLINGTON, Ontario, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Middle-aged adults are failing in the fight against frailty. Health officials say age-related muscle and strength loss, or sarcopenia, will...

Seattle, Dec. 06, 2018 (GLOBE NEWSWIRE) -- AstaMed, the Bellevue-based biotech pioneer with a new medical protocol currently available for the management of sarcopenia, announced a new nationwide...